Clover Health Investments Corp
F:7QD

Watchlist Manager
Clover Health Investments Corp Logo
Clover Health Investments Corp
F:7QD
Watchlist
Price: 2.11 EUR 5.5% Market Closed
Market Cap: €1B

P/B

4.1
Current
23%
More Expensive
vs 3-y average of 3.3

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
4.1
=
Market Cap
€1B
/
Total Equity
$308.7m

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
4.1
=
Market Cap
€1B
/
Total Equity
$308.7m

Valuation Scenarios

Clover Health Investments Corp is trading above its 3-year average

If P/B returns to its 3-Year Average (3.3), the stock would be worth €1.71 (19% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-38%
Maximum Upside
No Upside Scenarios
Average Downside
25%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 4.1 €2.11
0%
3-Year Average 3.3 €1.71
-19%
5-Year Average 3.3 €1.69
-20%
Industry Average 3.1 €1.61
-24%
Country Average 2.5 €1.3
-38%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close
Market Cap P/B P/E
US
Clover Health Investments Corp
F:7QD
1.3B EUR 4.1 -14.7
US
UnitedHealth Group Inc
NYSE:UNH
322.2B USD 3.1 26.7
US
Anthem Inc
LSE:0HG8
89.2B USD 2 17
US
Elevance Health Inc
NYSE:ELV
74.9B USD 1.7 14.3
US
Humana Inc
NYSE:HUM
26B USD 1.5 21.8
US
Centene Corp
NYSE:CNC
20.6B USD 1 -3.1
US
Molina Healthcare Inc
NYSE:MOH
9.1B USD 2.2 48.7
US
Healthequity Inc
NASDAQ:HQY
7B USD 3.3 32.6
US
Magellan Health Inc
F:MAH1
2.2B EUR 1.3 8.5
BR
Odontoprev SA
BOVESPA:ODPV3
8.3B BRL 6.4 14
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 2.9 25.4
P/E Multiple
Earnings Growth PEG
US
Clover Health Investments Corp
F:7QD
Average P/E: 23.2
Negative Multiple: -14.7
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
26.7
22%
1.2
US
A
Anthem Inc
LSE:0HG8
17
10%
1.7
US
Elevance Health Inc
NYSE:ELV
14.3
10%
1.4
US
Humana Inc
NYSE:HUM
21.8
38%
0.6
US
Centene Corp
NYSE:CNC
Negative Multiple: -3.1 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
48.7
14%
3.5
US
Healthequity Inc
NASDAQ:HQY
32.6
32%
1
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
BR
Odontoprev SA
BOVESPA:ODPV3
14
4%
3.5
US
Progyny Inc
NASDAQ:PGNY
25.4
35%
0.7

Market Distribution

In line with most companies in the United States of America
Percentile
62st
Based on 10 946 companies
62st percentile
3.5
Low
0 — 1.5
Typical Range
1.5 — 4.8
High
4.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.5
Median 2.5
70th Percentile 4.8
Max 147 580.5

Clover Health Investments Corp
Glance View

Market Cap
1B EUR
Industry
Health Care

Clover Health Investments Corp. embarked on a mission to transform the healthcare landscape with its innovative approach as a next-generation Medicare Advantage insurer. Born out of the need to reduce inefficiencies and enhance care, Clover Health uses its proprietary technology platform, the Clover Assistant, to arm physicians with data-driven insights that facilitate informed decision-making at the point of care. By integrating technology with healthcare delivery, Clover targets not only the evident administrative wastage but also addresses the structural challenges faced by patients and providers alike. This unique integration of digital tools with a traditional insurance model sets Clover apart in an industry ripe for disruption. Revenue for Clover Health primarily comes from Medicare Advantage premiums, where it competes by offering cost-effective plans combined with improved service. The company augments its financial model through government reimbursements tied to patient outcomes and the quality of care. Central to this strategy is the effective use of data analytics to manage patient care, reduce medical costs, and improve customer satisfaction. This alignment of financial incentives—lowering costs while enhancing patient outcomes—fuels Clover’s growth narrative, positioning it as a key player in reshaping how Medicare Advantage operates at the intersection of technology and healthcare delivery.

7QD Intrinsic Value
3.89 EUR
Undervaluation 46%
Intrinsic Value
Price €2.11
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett